Cardiology

University of Wisconsin

Questions discussed in this category

What is your approach to adjuvant HER-2 directed therapy in a patient who developed cardiotoxicity following neoadjuvant TC-HP?

Can these patients be re-challenged with Herceptin?

6 Answers available

Related Topics in Cardiology